title: The C-terminal tail of tetraspanin protein CD9 contributes to its function and molecular organization.
abstract: Tetraspanin protein CD9 supports sperm-egg fusion, and regulates cell adhesion, motility, metastasis, proliferation and signaling. The large extracellular loop and transmembrane domains of CD9 engage in functionally important interactions with partner proteins. However, neither functional nor biochemical roles have been shown for the CD9 C-terminal tail, despite it being highly conserved throughout vertebrate species. To gain new insight into the CD9 tail, three C-terminal amino acids (Glu-Met-Val) were replaced with residues corresponding to C-terminal amino acids from tetraspanin protein CD82 (Pro-Lys-Tyr). Wild-type and mutant CD9 were then stably expressed in MOLT-4, K562, U937, RD and HT1080 cells. Whereas wild-type CD9 inhibited cell adhesion and spreading on fibronectin, mutant CD9 did not. Wild-type CD9 also promoted homotypic cell-cell aggregation and microvilli formation, whereas mutant CD9 did not. Protein interactions of wild-type and mutant CD9 were compared quantitatively using stable isotope labeling with amino acids in cell culture (SILAC) in conjunction with liquid-chromatography-tandem mass spectrometry (LC-MS/MS) technology. SILAC results showed that, despite wild-type and mutant CD9 having identical expression levels, mutant CD9 and its major transmembrane interacting partners were recovered in substantially reduced amounts from 1% Brij 96 lysates. Immunoprecipitation experiments confirmed that mutant CD9 recovery was decreased in Brij 96, but not in more stringent Triton X-100 detergent. Additionally, compared with wild-type CD9 complexes, mutant CD9 complexes were larger and more oligomerized in Brij 96 detergent, consistent with decreased Brij 96 solubility, perhaps due to more membrane domains packing more tightly together. In conclusion, multiple CD9 functions depend on its C-terminal tail, which affects the molecular organization of CD9 complexes, as manifested by their altered solubilization in Brij 96 and organization on the cell surface.
authors.affiliation: Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute and Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.
authors.forename: Hong-Xing
authors.initials: HX
authors.lastname: Wang
authors.forename: Tatiana V
authors.initials: TV
authors.lastname: Kolesnikova
authors.forename: Carilee
authors.initials: C
authors.lastname: Denison
authors.forename: Steven P
authors.initials: SP
authors.lastname: Gygi
authors.forename: Martin E
authors.initials: ME
authors.lastname: Hemler
mesh_terms: D002448:Cell Adhesion / Q000235:genetics; D002465:Cell Movement / Q000235:genetics; D006801:Humans; D020014:K562 Cells; D051861:Kangai-1 Protein / Q000235:genetics / Q000378:metabolism*; D016297:Mutagenesis, Site-Directed; D009154:Mutation / Q000235:genetics; D011485:Protein Binding / Q000235:genetics; D055503:Protein Multimerization / Q000235:genetics; D020836:Protein Structure, Quaternary; D017434:Protein Structure, Tertiary / Q000235:genetics; D060245:Tetraspanin 29 / Q000235:genetics / Q000378:metabolism*; D059470:Tetraspanins / Q000235:genetics / Q000378:metabolism*; D019076:Transgenes / Q000235:genetics; D020298:U937 Cells
chemical_list: D051861:Kangai-1 Protein; D060245:Tetraspanin 29; D059470:Tetraspanins